Hormonal contraceptives like pills and IUDs can safely suppress menstruation by atrophying the endometrium, eliminating natural bleeding cycles. Women choosing to stop menstruating cite severe cramps, heavy bleeding, and PMS as primary reasons, though cultural and psychological connections to menstruation persist.
Suspender menstruação com anticoncepcionais: riscos, benefícios e o que muda no corpo
Related Coverage
Trump lança ofensiva contra estrangeiros suspendendo entrevistas de imigração, preparando revogação de até 200 mil visto…
Google News · Aug 29 Lula e Flávio Bolsonaro em sabatina da Globo: quem se saiu melhor?Lula e Flávio Bolsonaro participaram de entrevistas na TV Globo após o Jornal Nacional, gerando análises sobre desempenh…
Folha de S.Paulo · Aug 29 Lula nega problema da dívida pública em sabatina e enfraquece credibilidadeLula afirmou no Jornal Nacional não estar preocupado com crescimento da dívida pública, que atingiu 81,9% do PIB. Analis…
Folha de S.Paulo · Aug 29 Rock in Rio na 11ª edição equilibra rock e pop com DJ headliner inéditoO Rock in Rio chega à 11ª edição com estratégia renovada, equilibrando rock e pop entre sete headliners que incluem Foo …
Bias & Framing
Article presents menstrual suppression via hormonal contraceptives as safe and empowering, centering women's experiences while framing cultural skepticism as 'machista' without substantial counterargument.
Personal narrative framing combined with medical legitimacy. The article centers individual women's autonomy and frames menstruation as optional suffering, while positioning skeptics as culturally backward ('machista expectations'). Medical safety is asserted but not deeply examined.
Geopolitical Impact
This is a domestic health/lifestyle article about Brazilian women using hormonal contraceptives to suppress menstruation; it has no geopolitical implications.
N/A - This article concerns personal medical choices and reproductive health, not international relations or geopolitical dynamics.
Economic Lens
Growing adoption of hormonal contraceptives to suppress menstruation in Brazil reflects shifting consumer preferences toward health and quality-of-life improvements, with potential implications for pharmaceutical demand and healthcare spending.
Consumers benefit from expanded contraceptive options and reduced healthcare costs associated with menstrual symptom management (pain relief, reduced absenteeism). Increased demand for hormonal IUDs and continuous-use contraceptives may raise out-of-pocket costs for some, though long-term savings from reduced medical visits could offset expenses.
Potential for expanded insurance coverage of hormonal contraceptives and IUDs; need for standardized medical guidelines on menstrual suppression; increased healthcare education campaigns; possible regulatory review of off-label contraceptive use patterns; consideration of reproductive autonomy in healthcare policy frameworks.